Pharmacotherapy of atrial fibrillation: an old option with new possibilities
Authors:
- 1 April 2008
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 9 (6) , 913-925
Abstract
Background: Atrial fibrillation is the most common sustained arrhythmia observed worldwide. Despite modern ablative treatment options, pharmacotherapy remains the first-line therapy in patients with atrial fibrillation. Objective: Based on recently published guidelines for the management of atrial fibrillation, the present paper reviews the current and emerging concepts of pharmacotherapy in atrial fibrillation. Methods: A MEDLINE search was conducted using the keyword ‘atrial fibrillation’ and ‘drug therapy’. The reviewed literature included clinical trials and published reviews as well as clinical guidelines. Results: The mainstay of atrial fibrillation therapy is the prevention of thromboembolic events. With growing knowledge of the pathophysiology of atrial fibrillation new drug targets have been identified that promise improved outcomes in atrial fibrillation management and this will allow individual drug treatment in the near future.Keywords
This publication has 94 references indexed in Scilit:
- Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future PrevalenceCirculation, 2006
- Tachycardia‐Induced Cardiomyopathy: A Review of LiteraturePacing and Clinical Electrophysiology, 2005
- Increasing Trends in Hospitalization for Atrial Fibrillation in the United States, 1985 Through 1999Circulation, 2003
- Increased Atrial Fibrillation Mortality: United States, 1980-1998American Journal of Epidemiology, 2002
- Quality of life in patients with paroxysmal atrial fibrillation and its predictors: importance of the autonomic nervous systemEuropean Heart Journal, 2001
- The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapyJACC, 2000
- Impact of Atrial Fibrillation on the Risk of DeathCirculation, 1998
- Impact of Atrial Fibrillation on Mortality, Stroke, and Medical CostsArchives of internal medicine (1960), 1998
- Secular trends in the prevalence of atrial fibrillation: The Framingham studyAmerican Heart Journal, 1996
- Characteristics and Prognosis of Lone Atrial FibrillationJAMA, 1985